Three Geneva startups including a sustainable mobility project granted FIF Funding
Summary
The company integrates advanced engineering with digital tools to enhance functionality and user experience while prioritizing responsible sourcing and local assembly. The company will also be able to scale up production through an innovative collaboration with the Pro Foundation in Geneva.ETHZ spin-off Immitra Bio is pioneering genetic medicine to develop transformative treatments for rare diseases by combining hematopoietic stem cells (HSCs) with CRISPR-Cas9 gene editing. Their proprietary HematoGen platform enables precise and durable gene modifications within blood stem cells, addressing the root causes of genetic disorders. Immitra Bio is led by CEO and co-founder Jan Nelis, with a team dedicated to unlocking the potential of genetic cures. The company plans to move their headquarters to Geneva.The FIF Seed Loan will support this startup in advancing its efforts to treat rare diseases while also fostering new collaborations with Genevas world-class research institutes in this field.Led by engineer Alexandre Saconney-Pfister in collaboration with the Centre Assal research team, the project "Patient-specific post-operative orthoses for hallux valgus," initiated by Dr. Victor Dubois-Ferri\xe8re, aims to optimize post-operative care to improve clinical outcomes.Thanks to 3D printing, these orthoses simplify hospital care while ensuring better patient comfort throughout the healing process.